나이지리아 고객, 협력 논의 위해 WIXBIO 방문
In July 2023, WIXBIO welcomed a customer delegation from Nigeria. The two sides had an in-depth discussion on the customized cooperation of poultry vaccines and veterinary drugs. The visit not...
아프리카 고객, WixBio 콕시듐증 4가 생백신 재주문
On December 11, 2025, WixBio successfully fulfilled a repeat order from an African customer, supplying coccidiosis tetravalent live vaccine in the 1,000-dose presentation. The product has gained broad acceptance across...
WixBio, 베트남 고객에게 조류 인플루엔자 H5+H9 불활화 백신 전달
On December 9, 2025, WixBio successfully delivered a shipment of bivalent inactivated avian influenza (H5+H9) vaccine to a customer in Vietnam. The shipment consisted of products in 250 mL and...
WixBio, 대장균, 파스퇴렐라 및 살모넬라 불활성화 백신을 나이지리아에 예정보다 앞서 인도
On September 28, 2025, WixBio successfully fulfilled a critical air shipment order to Lagos, Nigeria, delivering 130 units of inactivated vaccines for poultry and livestock ahead of schedule. The shipment...
WixBio와 카자흐스탄 UNIVET사, 심층 기술 교류 진행
Nanjing, China, September 2025 — WixBio’s Overseas Business and Technical Departments recently hosted a face-to-face technical exchange meeting in Nanjing with representatives from UNIVET, a partner company from Kazakhstan. The...
WixBio, 터키에 맞춤형 4가 백신 공급
WixBio recently supplied 2,000 bottles of 500ml quadrivalent inactivated vaccine for Newcastle Disease (ND), Infectious Bronchitis (IB), Avian Influenza (H9), and Fowl Adenovirus (FADV) to a Turkish client. This product...
이라크로 발송된 가금류 백신 11,000병
On July 28, 2025, in Beijing, China, WixBio completed another delivery of 11,000 vials of customized poultry vaccine to clients in Iraq. Building on trust in product quality and consistent...
베트남 고객이 맞춤형 조류 인플루엔자 다가 백신을 재주문합니다
On July 24, 2025, in Zhengzhou, China, based on the local avian influenza epidemic situation in Vietnam, WixBio tailored an avian influenza H5 (N6+N8)+H9N2+Newcastle Disease (ND, G-7 strain) multivalent inactivated...
터키 고객, 6가 가금류 백신 재주문
On July 15, 2025, in Zhengzhou, China, WixBio fulfilled a repeat order from a Turkish client, shipping 4,000 bottles of 500ml inactivated hexavalent vaccine (a six-in-one shot) for Newcastle Disease...
WIXBIO, 러시아 고객과 협력 의향서 체결
Recently, Mr. Fang Fangshuo, a key partner from Russia, accompanied by translator Ms. Zhang, visited WixBio for detailed discussions on product customization and technical cooperation, ending with a signed letter...
WIXBIO 임원진, 중국-에티오피아 국제 과학 기술 협력 세미나 참석
May 30, 2025, Binzhou, Shandong — Senior representatives from WIXBIO were invited to the “2025 High-Level Foreign Experts Qilu Tour and China-Ethiopia International Science and Technology Cooperation Seminar” in Binzhou,...
WIXBIO, GPS 온도 추적기를 활용해 콜드체인 운송 품질 보장하며 서비스 업그레이드
May 28, 2025, Shandong, China — Wixbio has enhanced its services again, using advanced GPS temperature trackers for its latest Turkey order to ensure product quality and timely delivery. This...
Wixbio, 이란 ICD Group 방문해 파트너십 합의 도출하고 성공적으로 협약 체결
May 16, 2025, China - Wixbio’s CEO, head of the overseas business division, and Middle East sales manager visited Iran in mid-May to visit and evaluate the ICD Group. The...
Wixbio, 맞춤형 IBH 3가 불활화 백신 1000병 이라크로 출하
Shandong, China, May 14, 2025 -- Wixbio announced the successful shipment of 1,000 500 ml vials of its triple inactivated Infectious Bronchitis (IBH) Types 4, 8, and 11 vaccine to...
조류 인플루엔자(H5+H9) 불활화 백신 6,000병 베트남으로 출하
May 14, 2025, Shandong, China -- Wixbio has successfully completed a major order for 6,000 500ml vials of inactivated avian influenza (H5+H9) vaccine from its Shandong production base to a...
Wixbio, 터키에 대량 맞춤형 백신 다시 출하
Shandong, China, May 14, 2025 -- Wixbio today announced the successful shipment of another large-scale order for the Turkish market, totaling 10,500 500 500 ml vials of the triple custom...
베트남으로 맞춤형 오리 아데노바이러스 불활화 백신 출하
Shandong, China, May 7, 2025 -- Wixbio today announced the successful shipment of its customized Duck Adenovirus Inactivated Vaccine from its manufacturing site for customers in Vietnam. The shipment includes...
이라크 고객, Wixbio 방문해 백신 제품과 기술 학습
Wednesday, May 7, 2025 -- A customer from Iraq recently arrived at Wixbio's manufacturing facility in China for a fruitful visit and exchange. The purpose of the visit was to...
WIXBIO, 이라크 고객에게 가금류 백신 14,000바이알 인도
Beijing, April 30, 2025 — A significant shipment of animal vaccines has been airlifted from Beijing to Baghdad, Iraq, to support Iraqi clients in preventing and controlling poultry diseases. The...
맞춤형 오리 유자체(Reo) 불활화 백신, 베트남 고객에게 출하
Shandong, China, April 29, 2025 -- Wixbio announced the successful shipment of customized samples of inactivated duck eutheria (Reo) vaccine for the Vietnam market. The shipment includes 500 vials of...
WixBio, 베트남 고객에게 AI 백신 및 의약품 전달
April 28, 2025, Shandong, China—WixBio has shipped a refrigerated container of AI vaccines, Newcastle Disease triple vaccine, and veterinary drugs from Shandong to Vietnam. This shipment will provide Vietnam's poultry...
WixBio 신형 아데노바이러스 백신, 이라크로 출하
Recently, WixBio ND-AI-IBH Vaccine (Newcastle Disease, Influenza, and Adenovirus Triple Vaccine), an inactivated poultry vaccine, was successfully shipped to the Middle East. This cooperation marks another important milestone for Wixbio...
러시아 기업 PHARMINDUSTRIA, WIXBIO 방문
In December 2024, Mr. SAFAROV, CEO of PHARMINDUSTRIA from Russia, and Mr. SIDAROVICH from Belarus were invited to visit our company WIXBIO, the purpose of the visit is to strengthen the communication...
2024 국제 동물 의약품 산업 기술 심포지엄
From December 11~13, 2024, Wixbio participated in the 2024 high-level foreign expert Qiluxing and International Animal Medicine Industry Technology Seminar held at Binzhou Institute of Animal Husbandry and Veterinary Medicine in...
WIXBIO, 베트남 방문 및 CNC와 계약 체결
In November 2023, a WIXBIO delegation went to Vietnam for a three-day study visit and signed a strategic cooperation agreement with CNC, a well-known local company. The purpose of the...
2023 WIXBIO, 모스크바 축산 박람회 참가
On June 24, 2023, WIXBIO participated in the International Livestock Exhibition in Moscow. During this exhibition, WIXBIO presented its latest innovations and technical services: Innovative Vaccine Showcase: A number of...
파키스탄 대리인, WIXBIO의 백신 및 수의학 공장 방문
In September 2023, WIXBIO welcomed a delegation of agents from Pakistan, who paid a two-day visit to the company's vaccine and veterinary drug plants. The purpose of the visit was...
이집트 고객 Dr Essam, WIXBIO 공장 및 연구소 방문
In June 2024, Dr. Essam, the CEO of DWA PHARMA FOR PHARMACEUTICAL INDUSTRIES AND COSMETICS COMPANY from Egypt, was invited to visit WIXBIO's animal vaccine manufacturing facility. During his visit,...
이라크 고객 Alaq, Al-Shaheen, WIXBIO 방문
In March 2024, WIXBIO welcomed a delegation from Alaq, Al-Shaheen Co. for Trading of Veterinary Medicines, Pesticides, and Agriculture Supplies Ltd (from now on referred to as Alaq, Al-Shaheen Co.)....
케냐 파트너 Atlantis Pharmaceuticals, WIXBIO 방문
In October 2023, WIXBIO welcomed an official visit from Dr Geoffery, Managing Director, and Dr Nicky, Sales Director of Atlantis Pharmaceuticals from Kenya. This visit is an essential step for...
베트남 CNC 대표, 협력 강화를 위해 윅스바이오(WIXBIO) 방문
In May 2024, Nguyen Minh, Chairman of Vietnam CNC Veterinary Production and Trading Joint Stock Company (AniVacC Jsc.), and his delegation visited WIXBIO. They aimed to exchange in-depth information on...